SCI时时刷

search
Selective Targeting of RET Fusions in Lung Cancer
Selective Targeting of RET Fusions in Lung Cancer
Selective Targeting of RET Fusions in Lung CancerThe following represents disclosure information provided by authors of th...
Radio- or Chemotherapy Dose Escalation for Organ Preservation in Rectal Cancer?
Radio- or Chemotherapy Dose Escalation for Organ Preservation in Rectal Cancer?
"Radio- or Chemotherapy Dose Escalation for Organ Preservation in Rectal Cancer?." Journal of Clinical Oncology, , pp. –© ...
Surveillance Strategies in Endometrial Cancer Care: Why Less Represents Progress
Surveillance Strategies in Endometrial Cancer Care: Why Less Represents Progress
© 2022 by American Society of Clinical OncologyTHE TAKEAWAYIn the article by Zola et al13 that accompanies this editorial,...
Poly(ADP-Ribose) Polymerase Inhibitors in the Management of Ovarian Cancer: ASCO Guideline Rapid Recommendation Update
Poly(ADP-Ribose) Polymerase Inhibitors in the Management of Ovarian Cancer: ASCO Guideline Rapid Recommendation Update
ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline recommendations as a response to the emerg...
Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline
Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline
PURPOSEThe aim of this joint guideline is to provide evidence-based recommendations to practicing physicians and other hea...
Interpretation of the OPRA Study: Are Our Criteria Reliable Enough to Recommend Watch and Wait?
Interpretation of the OPRA Study: Are Our Criteria Reliable Enough to Recommend Watch and Wait?
"Interpretation of the OPRA Study: Are Our Criteria Reliable Enough to Recommend Watch and Wait?." Journal of Clinical Onc...
Quantifying Clinical Utility of Enzalutamide for Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer
Quantifying Clinical Utility of Enzalutamide for Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer
© 2022 by American Society of Clinical OncologyAUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTERESTQuantifying Clinical...
Clarifying the Equivocal Diagnosis of Cervical Intraepithelial Neoplasia 2: Still a Work in Progress
Clarifying the Equivocal Diagnosis of Cervical Intraepithelial Neoplasia 2: Still a Work in Progress
Published by American Society of Clinical OncologyAUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTERESTClarifying the Eq...
Ripretinib and the Failure to Advance GI Stromal Tumor Therapy in the Age of Precision Medicine
Ripretinib and the Failure to Advance GI Stromal Tumor Therapy in the Age of Precision Medicine
Ripretinib and the Failure to Advance GI Stromal Tumor Therapy in the Age of Precision MedicineThe following represents di...
Freeing the Competition: Will Aumolertinib (AENEAS) Have a Fighting Chance Against Osimertinib (FLAURA)?
Freeing the Competition: Will Aumolertinib (AENEAS) Have a Fighting Chance Against Osimertinib (FLAURA)?
We discuss clinical efficacy of aumolertinib in EGFR-mutated NSCLC (AENEAS trial) and its possible regulatory fate.
Reply to M. Lv et al
Reply to M. Lv et al
© 2022 by American Society of Clinical OncologyAUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTERESTReply to M. Lv et al...
Reply to M.S. Ewer et al
Reply to M.S. Ewer et al
© 2022 by American Society of Clinical OncologySUPPORTNational Cancer Institute (R01 CA214057) and National Cancer Institu...
Blood Pressure Classification Using the 2017 ACC/AHA Guideline and Heart Failure in Patients With Cancer
Blood Pressure Classification Using the 2017 ACC/AHA Guideline and Heart Failure in Patients With Cancer
PURPOSEDespite the growing recognition of the importance of hypertension in patients with cancer, little is known about wh...
Assessment of the Clinical Utility of Pretreatment DPYD Testing for Patients Receiving Fluoropyrimidine Chemotherapy
Assessment of the Clinical Utility of Pretreatment DPYD Testing for Patients Receiving Fluoropyrimidine Chemotherapy
PURPOSEPatients who carry pathogenic variants in DPYD have higher systemic fluoropyrimidine (FP) concentrations and greate...
Primary CNS Lymphoma: Progress With Dose-Intensive Consolidation
Primary CNS Lymphoma: Progress With Dose-Intensive Consolidation
The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A c...
Reply to R. Nishihara et al
Reply to R. Nishihara et al
Reply to R. Nishihara et alThe following represents disclosure information provided by authors of this manuscript. All rel...
Reply to P. Castle et al
Reply to P. Castle et al
Reply to P. Castle et alThe following represents disclosure information provided by authors of this manuscript. All relati...
Just and Equitable Enrollment to Pivotal Clinical Trials in Hematologic Malignancies
Just and Equitable Enrollment to Pivotal Clinical Trials in Hematologic Malignancies
Just and Equitable Enrollment to Pivotal Clinical Trials in Hematologic MalignanciesThe following represents disclosure in...
We All Seem to Agree: Exercise Is Medicine in Medical Oncology
We All Seem to Agree: Exercise Is Medicine in Medical Oncology
We All Seem to Agree: Exercise Is Medicine in Medical OncologyThe following represents disclosure information provided by ...